tgAAC 09
Alternative Names: Gag-PR-RT AAV HIV vaccine; HIV vaccine - Targeted Genetics; tgAAC-09Latest Information Update: 14 May 2019
At a glance
- Originator Targeted Genetics
- Developer Columbus Childrens Hospital; International AIDS Vaccine Initiative; Targeted Genetics Corporation; The Childrens Hospital of Philadelphia
- Class AIDS vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 09 May 2019 C3J Therapeutics has merged with AmpliPhi Biosciences Corporation to form Armata Pharmaceuticals
- 12 Mar 2007 Data presented at the 14th Conference on Retroviruses and Opportunistic Infections (CROI-2007) added to the adverse events and Viral Infections immunogenicity sections
- 12 Mar 2007 Phase-I clinical trials in HIV infections prevention in European Union (IM)